# A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

> **NCT00880581** · PHASE2 · COMPLETED · sponsor: **Ronald Levy** · enrollment: 30 (actual)

## Conditions studied

- Lymphoma, Non-Hodgkin
- Lymphoma
- Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell
- Lymphomas: Non-Hodgkin

## Interventions

- **DRUG:** PF-3512676
- **RADIATION:** Local radiotherapy

## Key facts

- **NCT ID:** NCT00880581
- **Lead sponsor:** Ronald Levy
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-09
- **Final completion:** 2015-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880581, "A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00880581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*